Effectiveness of zopiclone in disorders of initiating and maintaining sleep.
Results of a drug monitoring study in 811 general practices
by
Wiegand MH, Roszinsky-Kocher G, Schwalb B, Fischer W, Eckert MW.
Klinik und Poliklinik fur Psychiatrie
und Psychotherapie der Technischen Universitat Munchen.
Fortschr Med Orig 2001;119(1):25-32

ABSTRACT

BACKGROUND AND METHOD: In a drug monitoring study with 811 participating general practitioners, safety and tolerability of zopiclone were studied in 2416 patients with disorders of initiating and maintaining sleep. RESULTS: In general, zopiclone was efficient in all forms of insomnia; the subjective sleep duration was prolonged for 2 hours on average. Patients without somatic complaints or comorbidity showed the greatest benefit. Daytime well-being and vigilance were in general not impaired. Drug related adverse events occurred rarely; the great majority of the participating physicians rated the treatment with zopiclone as efficient and acceptable. CONCLUSION: In this drug monitoring study, zopiclone proved an efficient hypnotic for the treatment of disorders of initiating and maintaining sleep.

Insomnia
Sedatives
Alprazolam
Benzodiazepines
Zopiclone drivers
Sleeping-pill hype?
Zopiclone: structure
Zopiclone v zolpidem
Eszopiclone (Lunesta)
Zopiclone: pharmacokinetics
Zopiclone (Imovane) : structure
Zopiclone and desmethylzopiclone
Nightly eszopiclone (Lunesta) for insomniacs
Eszopiclone (Lunesta): prescribing information (PDF)
The new sleeping pills: Lunesta, Sonata and Rozerem

Refs
and further reading

HOME
HedWeb
Nootropics
Cocaine.org
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family